Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biomarin Pharmaceuticals (NQ: BMRN )

82.97 USD +1.61 (+1.98%)
Official Closing Price Updated: 7:59 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,306,500
Open 81.72
Bid (Size) 81.51 (2)
Ask (Size) 83.50 (1)
Prev. Close 81.36
Today's Range 81.25 - 83.63
52wk Range 68.25 - 131.94
Shares Outstanding 176,713,314
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
BioMarin Announces Positive Phase 3 Gene Therapy Trial Results in Adults with Severe Hemophilia A; Study Met All Primary and Secondary Efficacy Endpoints in One-Year Data Set
- Significantly Reduced Mean Annualized Bleeding Rate by 84% (p-value <0.0001) Demonstrating Superiority to Factor VIII Prophylaxis, and Reduced Mean Annualized Factor VIII Infusion Rate by 99%... 
From PR Newswire
BioMarin to Participate in Two Upcoming Virtual Investor Conferences
- Goldman Sachs 13th Annual Healthcare CEOs Unscripted Conference: A View from the Top on January 5 at 12:35pm ET 
From PR Newswire

Performance

YTD
-3.86%
-3.86%
1 Month
-7.07%
-7.07%
3 Month
+4.69%
+4.69%
6 Month
-35.29%
-35.29%
1 Year
-6.91%
-6.91%

More News

Read More
BioMarin Announces Benefit Maintained for Over Two Years in Children with Achondroplasia Treated with Vosoritide in Phase 3 Extension Study
From PR Newswire
Noteworthy Monday Option Activity: PI, CROX, BMRN
Tags Stocks
From Market News Video
12 Health Care Stocks Moving In Monday's Intraday Session
Tags NH NVTA WVE
From Benzinga
BioMarin Pharmaceutical Larger Than S&P 500 Component Waters
Tags Stocks
From Market News Video
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Long Term Investor Notice: Investigation of Potential Wrongdoing
From SBWire - Latest Press Releases
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
Tags Health Care CVS BMRN
From Benzinga
BIOMARIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN
From Business Wire News Releases
Analysts Forecast 10% Gains Ahead For The Holdings of BBH
Tags ETFs
From ETF Channel
First Week of February 2021 Options Trading For BioMarin Pharmaceutical (BMRN)
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.